Fragile X-Related Protein FXR1 Controls Human Adenovirus Capsid mRNA Metabolism.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
28 02 2023
Historique:
pubmed: 8 2 2023
medline: 3 3 2023
entrez: 7 2 2023
Statut: ppublish

Résumé

Human adenoviruses (HAdVs) are widespread pathogens causing a variety of diseases. A well-controlled expression of virus capsid mRNAs originating from the major late transcription unit (MLTU) is essential for forming the infectious virus progeny. However, regulation of the MLTU mRNA metabolism has mainly remained enigmatic. In this study, we show that the cellular RNA-binding protein FXR1 controls the stability of the HAdV-5 MLTU mRNAs, as depletion of FXR1 resulted in increased steady-state levels of MLTU mRNAs. Surprisingly, the lack of FXR1 reduced viral capsid protein accumulation and formation of the infectious virus progeny, indicating an opposing function of FXR1 in HAdV-5 infection. Further, the long FXR1 isoform interfered with MLTU mRNA translation, suggesting FXR1 isoform-specific functions in virus-infected cells. We also show that the FXR1 protein interacts with N6-methyladenosine (m

Identifiants

pubmed: 36749074
doi: 10.1128/jvi.01539-22
pmc: PMC9972981
doi:

Substances chimiques

Capsid Proteins 0
FXR1 protein, human 0
RNA, Messenger 0
RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0153922

Références

Virology. 2015 Nov;485:25-35
pubmed: 26196231
PLoS One. 2010 Nov 02;5(11):e13559
pubmed: 21072162
Virology. 2021 Oct;562:92-102
pubmed: 34280810
J Biol Chem. 2006 Dec 1;281(48):36510-7
pubmed: 17028184
Virology. 1992 Jan;186(1):280-5
pubmed: 1727603
Cell Cycle. 2016 Jul 17;15(14):1874-82
pubmed: 27229378
Virus Res. 1993 Apr;28(1):67-90
pubmed: 8388142
Cell Rep. 2021 Nov 2;37(5):109934
pubmed: 34731628
Cell Rep. 2018 Jul 31;24(5):1176-1189
pubmed: 30067974
J Virol. 2006 May;80(10):5010-20
pubmed: 16641292
Nat Microbiol. 2020 Oct;5(10):1217-1231
pubmed: 32661314
Nature. 1996 Jun 6;381(6582):535-8
pubmed: 8632829
EMBO J. 1995 Jun 1;14(11):2401-8
pubmed: 7781595
FEBS Lett. 2020 Jun;594(12):1861-1878
pubmed: 32472693
Mol Cell. 2016 Mar 3;61(5):760-773
pubmed: 26942679
Hum Mol Genet. 2009 Sep 1;18(17):3164-77
pubmed: 19487368
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1795-1800
pubmed: 29225167
FEBS Lett. 2018 Sep;592(17):2845-2859
pubmed: 29782652
Cell. 1978 Oct;15(2):497-510
pubmed: 719751
Genes Dev. 1996 Jun 15;10(12):1557-67
pubmed: 8666238
Mol Cell Neurosci. 2008 Oct;39(2):170-9
pubmed: 18655836
Cell. 2007 Mar 23;128(6):1105-18
pubmed: 17382880
Hum Mol Genet. 1998 Dec;7(13):2121-8
pubmed: 9817930
PLoS One. 2016 May 02;11(5):e0154814
pubmed: 27136093
PLoS One. 2015 Sep 02;10(9):e0137102
pubmed: 26332038
Nat Commun. 2020 Nov 26;11(1):6016
pubmed: 33243990
EMBO J. 1999 Feb 15;18(4):1014-24
pubmed: 10022843
Crit Rev Biochem Mol Biol. 2020 Oct;55(5):409-424
pubmed: 32878499
PLoS Pathog. 2016 Aug 10;12(8):e1005810
pubmed: 27509095
Proc Natl Acad Sci U S A. 1986 Aug;83(16):5844-8
pubmed: 2942942
Nat Struct Mol Biol. 2017 Oct;24(10):870-878
pubmed: 28869609
Elife. 2017 Aug 02;6:
pubmed: 28767039
Clin Microbiol Rev. 2014 Jul;27(3):441-62
pubmed: 24982316
Nature. 2012 Dec 20;492(7429):382-6
pubmed: 23235829
Viruses. 2021 Feb 28;13(3):
pubmed: 33671079
J Proteome Res. 2017 Feb 3;16(2):872-888
pubmed: 27959563
FEBS Lett. 2020 Jun;594(12):1848-1860
pubmed: 31821536
Virology. 2016 May;492:242-50
pubmed: 27003248
Genes Dev. 2000 Feb 15;14(4):414-21
pubmed: 10691734
FEBS Lett. 2019 Dec;593(24):3531-3550
pubmed: 31764999
J Cell Biol. 2020 Apr 6;219(4):
pubmed: 32328638
J Virol. 2020 Nov 25;95(4):
pubmed: 33239457
Elife. 2019 Oct 24;8:
pubmed: 31647415
Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):E3808-E3816
pubmed: 29610341
J Virol. 2019 Jan 17;93(3):
pubmed: 30429337
J Virol. 2018 Jan 17;92(3):
pubmed: 29142133
Elife. 2018 Dec 04;7:
pubmed: 30511641
Sci Rep. 2017 Apr 4;7(1):618
pubmed: 28377580
EMBO J. 2001 Feb 15;20(4):864-71
pubmed: 11179230
Nature. 1998 May 14;393(6681):185-7
pubmed: 9603524
Genomics. 2001 Dec;78(3):169-77
pubmed: 11735223
Trends Cancer. 2019 Feb;5(2):82-84
pubmed: 30755307
Commun Biol. 2020 Mar 13;3(1):124
pubmed: 32170151

Auteurs

Zamaneh Hajikhezri (Z)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Yanina Kaira (Y)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Erik Schubert (E)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Mahmoud Darweesh (M)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Department of Microbiology and Immunology, Faculty of Pharmacy, Alazhr University, Assiut, Egypt.

Catharina Svensson (C)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Göran Akusjärvi (G)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Tanel Punga (T)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH